First Immunotherapy Approved for Gastric Cancer – Medscape
Medscape |
First Immunotherapy Approved for Gastric Cancer
Medscape The US Food and Drug Administration (FDA) today approved pembrolizumab (Keytruda, Merck) for treatment of gastric or gastroesophageal junction cancer. Pembrolizumab becomes the first immunotherapy approved in the United States for gastric cancer. |
